Abstract
Developmental exposure to stress hormones, i.e. glucocorticoids, is central to the process of prenatal programming of later-life health. Glucocorticoid overexposure, through stress or exogenous glucocorticoids, results in a reduced birthweight, as well as affective and neuropsychiatric outcomes in adults, combined with altered hypothalamus-pituitary-adrenal (HPA) axis activity. As such, glucocorticoids are tightly regulated during development through the presence of the metabolizing enzyme 11β-hydroxysteroid dehydrogenase type 2 (HSD2). HSD2 is highly expressed in 2 hubs during development, i.e. the placenta and the fetus itself, protecting the fetus from inappropriate glucocorticoid exposure early in gestation. Through manipulation of HSD2 expression in the mouse placenta and fetal tissues, we are able to determine the relative contribution of glucocorticoid exposure in each compartment. Feto-placental HSD2 deletion resulted in a reduced birthweight and the development of anxiety- and depression-like behaviours in adult mice. The placenta itself is altered by glucocorticoid overexposure, which causes reduced placental weight and vascular arborisation. Furthermore, altered flow and resistance in the umbilical vessels and modification of fetal heart function and development are observed. However, brain-specific HSD2 removal (HSD2BKO) also generated adult phenotypes of depressive-like behaviour and memory deficits, demonstrating the importance of fetal brain HSD2 expression in development. In this review we will discuss potential mechanisms underpinning early-life programming of adult neuropsychiatric disorders and the novel therapeutic potential of statins.
References
1.
Barker
DJ
. Fetal origins of coronary heart disease
. BMJ
. 1995
Jul
;311
(6998
):171
–4
.
[PubMed]
0959-81382.
Nomura
Y
, Wickramaratne
PJ
, Pilowsky
DJ
, Newcorn
JH
, Bruder-Costello
B
, Davey
C
, et al. Low birth weight and risk of affective disorders and selected medical illness in offspring at high and low risk for depression
. [Internet]
. Compr Psychiatry
. 2007
Sep-Oct
;48
(5
):470
–8
. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-34547828854&partnerID=tZOtx3y1
[PubMed]
0010-440X3.
Aarnoudse-Moens
CS
, Weisglas-Kuperus
N
, van Goudoever
JB
, Oosterlaan
J
. Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children
. [Internet]
. Pediatrics
. 2009
Aug
;124
(2
):717
–28
. Available from: http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2008-2816
[PubMed]
0031-40054.
Leijon
I
, Ingemansson
F
, Nelson
N
, Wadsby
M
, Samuelsson
S
. Reading deficits in very low birthweight children are associated with vocabulary and attention issues at the age of seven
. Acta Paediatr
. 2016
Jan
;105
(1
):60
–8
.
[PubMed]
0803-52535.
Shenkin
SD
, Starr
JM
, Pattie
A
, Rush
MA
, Whalley
LJ
, Deary
IJ
. Birth weight and cognitive function at age 11 years: the Scottish Mental Survey 1932
. Arch Dis Child
. 2001
Sep
;85
(3
):189
–96
.
[PubMed]
0003-98886.
Eide
MG
, Moster
D
, Irgens
LM
, Reichborn-Kjennerud
T
, Stoltenberg
C
, Skjærven
R
, et al. Degree of fetal growth restriction associated with schizophrenia risk in a national cohort
. Psychol Med
. 2013
Oct
;43
(10
):2057
–66
.
[PubMed]
0033-29177.
Rifkin
L
, Lewis
S
, Jones
P
, Toone
B
, Murray
R
. Low birth weight and schizophrenia
. Br J Psychiatry
. 1994
Sep
;165
(3
):357
–62
.
[PubMed]
0007-12508.
Lampi
KM
, Lehtonen
L
, Tran
PL
, Suominen
A
, Lehti
V
, Banerjee
PN
, et al. Risk of autism spectrum disorders in low birth weight and small for gestational age infants
. [Internet]
. J Pediatr
. 2012
Nov
;161
(5
):830
–6
.
[PubMed]
0022-34769.
Cottrell
EC
, Seckl
JR
. Prenatal stress, glucocorticoids and the programming of adult disease
. [Internet]
. Front Behav Neurosci
. 2009
Sep
;3
(September
):19
. Available from: http://journal.frontiersin.org/article/10.3389/neuro.08.019.2009/abstract
[PubMed]
1662-515310.
Holmes
MC
, Abrahamsen
CT
, French
KL
, Paterson
JM
, Mullins
JJ
, Seckl
JR
. The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids
. [Internet]
. J Neurosci
. 2006
Apr
;26
(14
):3840
–4
. Available from: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.4464-05.2006
[PubMed]
0270-647411.
Slotkin
TA
, Kreider
ML
, Tate
CA
, Seidler
FJ
. Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems
. [Internet]
. Neuropsychopharmacology
. 2006
May
;31
(5
):904
–11
. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16160705
[PubMed]
0893-133X12.
Noorlander
CW
, Tijsseling
D
, Hessel
EV
, de Vries
WB
, Derks
JB
, Visser
GH
, et al. Antenatal glucocorticoid treatment affects hippocampal development in mice
. PLoS One
. 2014
Jan
;9
(1
):e85671
.
[PubMed]
1932-620313.
Cartier
J
, Zeng
Y
, Drake
AJ
. Glucocorticoids and the prenatal programming of neurodevelopmental disorders
. [Internet]
. Curr Opin Behav Sci
. 2016
;7
:1
–7
. 2352-154614.
Sarabdjitsingh
RA
, Loi
M
, Joëls
M
, Dijkhuizen
RM
, van der Toorn
A
. Early life stress-induced alterations in rat brain structures measured with high resolution MRI
. PLoS One
. 2017
Sep
;12
(9
):e0185061
.
[PubMed]
1932-620315.
Stirrat
LI
, Walker
JJ
, Stryjakowska
K
, Jones
N
, Homer
NZ
, Andrew
R
, et al. Pulsatility of glucocorticoid hormones in pregnancy: changes with gestation and obesity
. Clin Endocrinol (Oxf)
. 2018
Apr
;88
(4
):592
–600
.
[PubMed]
0300-066416.
Duthie
L
, Reynolds
RM
. Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: influences on maternal and fetal outcomes
. Neuroendocrinology
. 2013
;98
(2
):106
–15
.
[PubMed]
0028-383517.
Fowden
AL
, Li
J
, Forhead
AJ
. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance?
[Internet]
. Proc Nutr Soc
. 1998
Feb
;57
(1
):113
–22
. Available from: http://www.journals.cambridge.org/abstract_S0029665198000202
[PubMed]
0029-665118.
Chapman
K
, Holmes
M
, Seckl
J
. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action
. [Internet]
. Physiol Rev
. 2013
Jul
;93
(3
):1139
–206
. Available from: http://physrev.physiology.org/cgi/doi/10.1152/physrev.00020.2012
[PubMed]
0031-933319.
Ballard
PL
, Ballard
RA
. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids
. Am J Obstet Gynecol
. 1995
Jul
;173
(1
):254
–62
.
[PubMed]
0002-937820.
Brown
RW
, Diaz
R
, Robson
AC
, Kotelevtsev
YV
, Mullins
JJ
, Kaufman
MH
, et al. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development
. Endocrinology
. 1996
Feb
;137
(2
):794
–7
.
[PubMed]
0013-722721.
Diaz
R
, Brown
RW
, Seckl
JR
. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions
. J Neurosci
. 1998
Apr
;18
(7
):2570
–80
.
[PubMed]
0270-647422.
Holmes
MC
, Sangra
M
, French
KL
, Whittle
IR
, Paterson
J
, Mullins
JJ
, et al. 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids
. [Internet]
. Neuroscience
. 2006
Feb
;137
(3
):865
–73
. Available from: http://www.sciencedirect.com/science/article/pii/S0306452205010961
[PubMed]
0306-452223.
Robson
AC
, Leckie
CM
, Seckl
JR
, Holmes
MC
. 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain
. Brain Res Mol Brain Res
. 1998
Oct
;61
(1-2
):1
–10
.
[PubMed]
0169-328X24.
Cottrell
EC
, Holmes
MC
, Livingstone
DE
, Kenyon
CJ
, Seckl
JR
. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming
. [Internet]
. FASEB J
. 2012
May
;26
(5
):1866
–74
. Available from: http://www.fasebj.org/cgi/doi/10.1096/fj.12-203489
[PubMed]
0892-663825.
Stirrat
LI
, Sengers
BG
, Norman
JE
, Homer
NZ
, Andrew
R
, Lewis
RM
, et al. Transfer and metabolism of cortisol by the isolated perfused human placenta
. J Clin Endocrinol Metab
. 2018
Feb
;103
(2
):640
–8
.
[PubMed]
0021-972X26.
Mark
PJ
, Waddell
BJ
. P-glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells
. Endocrinology
. 2006
Nov
;147
(11
):5147
–52
.
[PubMed]
0013-722727.
St-Pierre
M V
, Serrano
MA
, Macias
RIR
, Dubs
U
, Zu
C
-, Expression JJGM, et al. Expression of members of the multidrug resistance protein family in human term placenta. AJP Regul Integr Comp Physiol. 2000
;279:1495–503.28.
Lye
P
, Bloise
E
, Nadeem
L
, Gibb
W
, Lye
SJ
, Matthews
SG
. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta
. J Cell Mol Med
. 2018
Jul
;22
(7
):3652
–60
.
[PubMed]
1582-183829.
O’Donnell
KJ
, Bugge Jensen
A
, Freeman
L
, Khalife
N
, O’Connor
TG
, Glover
V
. Maternal prenatal anxiety and downregulation of placental 11β-HSD2
. [Internet]
. Psychoneuroendocrinology
. 2012
Jun
;37
(6
):818
–26
.
[PubMed]
0306-453030.
Peña
CJ
, Monk
C
, Champagne
FA
. Epigenetic effects of Prenatal stress on 11β-Hydroxysteroid Dehydrogenase-2 in the Placenta and fetal brain
. PLoS One
. 2012
;7
(6
):1
–9
.1932-620331.
New
MI
, Wilson
RC
. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess
. [Internet]
. Proc Natl Acad Sci USA
. 1999
Oct
;96
(22
):12790
–7
. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.96.22.12790
[PubMed]
0027-842432.
Debost
JC
, Petersen
L
, Grove
J
, Hedemand
A
, Khashan
A
, Henriksen
T
, et al. Investigating interactions between early life stress and two single nucleotide polymorphisms in HSD11B2 on the risk of schizophrenia
. [Internet]
. Psychoneuroendocrinology
. 2015
Oct
;60
:18
–27
.
[PubMed]
0306-453033.
Li
J
, Chen
YP
, Wang
ZN
, Liu
TB
, Chen
D
, Dong
YP
, et al. A functional fetal HSD11B2[CA]n microsatellite polymorphism is associated with maternal serum cortisol concentrations in pregnant women
. Kidney Blood Press Res
. 2013
;38
(1
):132
–41
.
[PubMed]
1420-409634.
Cottrell
EC
, Seckl
JR
, Holmes
MC
, Wyrwoll
CS
. Foetal and placental 11β-HSD2: a hub for developmental programming
. [Internet]
. Acta Physiol (Oxf)
. 2014
Feb
;210
(2
):288
–95
. Available from: http://doi.wiley.com/10.1111/apha.12187
[PubMed]
1748-170835.
Wyrwoll
CS
, Holmes
MC
. Prenatal excess glucocorticoid exposure and adult affective disorders: a role for serotonergic and catecholamine pathways
. Neuroendocrinology
. 2012
;95
(1
):47
–55
.
[PubMed]
0028-383536.
Seckl
JR
, Meaney
MJ
. Glucocorticoid programming
. [Internet]
. Ann N Y Acad Sci
. 2004
Dec
;1032
(44
):63
–84
. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15677396
[PubMed]
0077-892337.
Bailey
MA
. 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
. Curr Hypertens Rep
. 2017
Nov
;19
(12
):100
.
[PubMed]
1522-641738.
Bailey M a
. Craigie E, Livingstone DEW, Kotelevtsev Y V, Al-Dujaili E a S, Kenyon CJ, et al. Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure. Hypertension [Internet]. 2011
;57(3):515–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2128256139.
Kalisch-Smith
JI
, Simmons
DG
, Dickinson
H
, Moritz
KM
. Review: sexual dimorphism in the formation, function and adaptation of the placenta
. [Internet]
. Placenta
. 2017
Jun
;54
:10
–6
.
[PubMed]
0143-400440.
Burton
GJ
, Fowden
AL
, Thornburg
KL
. Placental Origins of Chronic Disease
. Physiol Rev
. 2016
Oct
;96
(4
):1509
–65
.
[PubMed]
0031-933341.
Morsing
E
, Asard
M
, Ley
D
, Stjernqvist
K
, Marsál
K
. Cognitive function after intrauterine growth restriction and very preterm birth
. [Internet]
. Pediatrics
. 2011
Apr
;127
(4
):e874
–82
. Available from: http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2010-1821
[PubMed]
0031-400542.
Baschat
AA
. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction
. Ultrasound Obstet Gynecol
. 2011
May
;37
(5
):501
–14
.
[PubMed]
0960-769243.
Shapira-Zaltsberg
G
, Grynspan
D
, Quintana
MV
, Dominguez
PC
, Reddy
D
, Davila
JH
, et al. MRI features of the placenta in fetuses with and without CNS abnormalities
. [Internet]
. Clin Radiol
. 2018
Sep
;73
(9
):836.e9
–15
.
[PubMed]
0009-926044.
Basilious
A
, Yager
J
, Fehlings
MG
. Neurological outcomes of animal models of uterine artery ligation and relevance to human intrauterine growth restriction: a systematic review
. Dev Med Child Neurol
. 2015
May
;57
(5
):420
–30
.
[PubMed]
0012-162245.
Perez-Garcia
V
, Fineberg
E
, Wilson
R
, Murray
A
, Mazzeo
CI
, Tudor
C
, et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants
. [Internet]
. Nature
. 2018
Mar
;555
(7697
):463
–8
.
[PubMed]
0028-083646.
Bonnin
A
, Goeden
N
, Chen
K
, Wilson
ML
, King
J
, Shih
JC
, et al. A transient placental source of serotonin for the fetal forebrain
. [Internet]
. Nature
. 2011
Apr
;472
(7343
):347
–50
.
[PubMed]
0028-083647.
Nugent
BM
, O ’donnell CM, Neill Epperson C, Bale TL. Placental H3K27me3 establishes female resilience to prenatal insults. Nat Commun [Internet]. 2018;(2018
):1–10. Available from: file:///Users/emilydavis/Downloads/Nugent_et_al-2018-Nature_Communications.pdf48.
Chan
JC
, Nugent
BM
, Bale
TL
. Parental Advisory: Maternal and Paternal Stress Can Impact Offspring Neurodevelopment
. [Internet]
. Biol Psychiatry
. 2018
May
;83
(10
):886
–94
.
[PubMed]
0006-322349.
Marsit
CJ
, Maccani
MA
, Padbury
JF
, Lester
BM
. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome
. PLoS One
. 2012
;7
(3
):e33794
.
[PubMed]
1932-620350.
Zhao
Y
, Gong
X
, Chen
L
, Li
L
, Liang
Y
, Chen
S
, et al. Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction
. [Internet]
. Eur J Hum Genet
. 2014
Jun
;22
(6
):734
–40
.
[PubMed]
1018-481351.
Hewitt
DP
, Mark
PJ
, Waddell
BJ
. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat
. Endocrinology
. 2006
Dec
;147
(12
):5568
–74
.
[PubMed]
0013-722752.
Hewitt
DP
, Mark
PJ
, Waddell
BJ
. Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure
. [Internet]
. Biol Reprod
. 2006
Jan
;74
(1
):23
–8
. Available from: https://academic.oup.com/biolreprod/article-lookup/doi/10.1095/biolreprod.105.045914
[PubMed]
0006-336353.
Wyrwoll
CS
, Seckl
JR
, Holmes
MC
. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice
. Endocrinology
. 2009
Mar
;150
(3
):1287
–93
.
[PubMed]
0013-722754.
Wyrwoll
CS
, Noble
J
, Thomson
A
, Tesic
D
, Miller
MR
, Rog-Zielinska
EA
, et al. Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess
. [Internet]
. Proc Natl Acad Sci USA
. 2016
May
;113
(22
):6265
–70
. Available from: http://www.pnas.org/lookup/doi/10.1073/pnas.1520356113
[PubMed]
0027-842455.
Neuvonen
PJ
, Backman
JT
, Niemi
M
. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
. Clin Pharmacokinet
. 2008
;47
(7
):463
–74
.
[PubMed]
0312-596356.
Ahmed
A
, Singh
J
, Khan
Y
, Seshan
SV
, Girardi
G
. A new mouse model to explore therapies for preeclampsia
. PLoS One
. 2010
Oct
;5
(10
):e13663
.
[PubMed]
1932-620357.
Garrett
N
, Pombo
J
, Umpierrez
M
, Clark
JE
, Simmons
M
, Girardi
G
. Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice
. [Internet]
. JCI Insight
. 2018
Apr
;3
(8
):120147
. Available from: https://insight.jci.org/articles/view/120147%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/29669946%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5931129
[PubMed]
2379-370858.
Wyrwoll
C
, Keith
M
, Noble
J
, Stevenson
PL
, Bombail
V
, Crombie
S
, et al. Fetal brain 11β-hydroxysteroid dehydrogenase type 2 selectively determines programming of adult depressive-like behaviors and cognitive function, but not anxiety behaviors in male mice
. [Internet]
. Psychoneuroendocrinology
. 2015
Sep
;59
:59
–70
. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0306453015001833
[PubMed]
0306-453059.
Rosenfeld
CS
. Sex-specific placental responses in fetal development
. Endocrinology
. 2015
Oct
;156
(10
):3422
–34
.
[PubMed]
0013-722760.
Appleton
AA
, Armstrong
DA
, Lesseur
C
, Lee
J
, Padbury
JF
, Lester
BM
, et al. Patterning in placental 11-B hydroxysteroid dehydrogenase methylation according to prenatal socioeconomic adversity
. PLoS One
. 2013
Sep
;8
(9
):e74691
.
[PubMed]
1932-620361.
Bonnin
A
, Torii
M
, Wang
L
, Rakic
P
, Levitt
P
. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1
. Nat Neurosci
. 2007
May
;10
(5
):588
–97
.
[PubMed]
1097-625662.
Hendricks
TJ
, Fyodorov
DV
, Wegman
LJ
, Lelutiu
NB
, Pehek
EA
, Yamamoto
B
, et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior
. Neuron
. 2003
Jan
;37
(2
):233
–47
.
[PubMed]
0896-627363.
St-Pierre
J
, Laurent
L
, King
S
, Vaillancourt
C
. Effects of prenatal maternal stress on serotonin and fetal development
. [Internet]
. Placenta
. 2016
Dec
;48
Suppl 1
:S66
–71
.
[PubMed]
0143-400464.
Van den Hove
DL
, Lauder
JM
, Scheepens
A
, Prickaerts
J
, Blanco
CE
, Steinbusch
HW
. Prenatal stress in the rat alters 5-HT1A receptor binding in the ventral hippocampus
. Brain Res
. 2006
May
;1090
(1
):29
–34
.
[PubMed]
0006-899365.
Medeiros
LR
, McDonald
MD
. Cortisol-mediated downregulation of the serotonin 1A receptor subtype in the Gulf toadfish, Opsanus beta
. [Internet]
. Comp Biochem Physiol A Mol Integr Physiol
. 2013
Apr
;164
(4
):612
–21
.
[PubMed]
1095-643366.
Chalmers
DT
, Kwak
SP
, Mansour
A
, Akil
H
, Watson
SJ
. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression
. [Internet]
. J Neurosci
. 1993
Mar
;13
(3
):914
–23
. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8441016
[PubMed]
0270-647467.
Bonnin
A
, Peng
W
, Hewlett
W
, Levitt
P
. Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development
. Neuroscience
. 2006
Aug
;141
(2
):781
–94
.
[PubMed]
0306-452268.
Meijer
OC
, Cole
TJ
, Schmid
W
, Schütz
G
, Joëls
M
, De Kloet
ER
. Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic mice with a targeted disruption of the glucocorticoid receptor
. Brain Res Mol Brain Res
. 1997
Jun
;46
(1-2
):290
–6
.
[PubMed]
0169-328X69.
Räikkönen
K
, Pesonen
AK
, O’Reilly
JR
, Tuovinen
S
, Lahti
M
, Kajantie
E
, et al. Maternal depressive symptoms during pregnancy, placental expression of genes regulating glucocorticoid and serotonin function and infant regulatory behaviors
. Psychol Med
. 2015
Nov
;45
(15
):3217
–26
.
[PubMed]
0033-291770.
Bronson
SL
, Chan
JC
, Bale
TL
. Sex-Specific Neurodevelopmental Programming by Placental Insulin Receptors on Stress Reactivity and Sensorimotor Gating
. [Internet]
. Biol Psychiatry
. 2017
Jul
;82
(2
):127
–38
.
[PubMed]
0006-3223© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
